18F-FMISO PET imaging and efficacy of eribulin in metastatic breast cancer
Not Applicable
Recruiting
- Conditions
- metastatic breast cancer
- Registration Number
- JPRN-UMIN000014173
- Lead Sponsor
- breast surgery Hokkaido University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Female
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
none
Study & Design
- Study Type
- Interventional,observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method SUV level of FMISO PET and the change after treatment of eribulin
- Secondary Outcome Measures
Name Time Method